As a result, this treatment has the potential to become a valuable addition to the current treatment options for CKD-MBD, offering a safe and effective alternative for patients who cannot tolerate other forms of treatment [91], [92], [93]
Yang Y, Wang L, Wang S, Wang Y, Du Y, Fan Y
Stockwell et al., 2017
Therefore, future efforts should prioritize the transition from preclinical studies to clinical trials, aimed at evaluating its safety and efficacy, ultimately providing innovative therapeutic strategies for cancer patients
By maintaining mitochondrial homeostasis and reducing oxidative stress, 2-APQC emerges as a potential candidate for treating heart failure and related cardiac conditions 188